Disease mongering in drug promotion: do governments have a regulatory role?
Text Size: Normal / Medium / Large
Printer-friendly versionResource Language:
English
Media Type:
Paper
Online
Examines activities financed by drug companies to promote sales by expanding the pool of patients potentially treated by their products, when no benefit in terms of reduced morbidity is likely.
Available From:
ISBN/ISSN:
ISSN 15491277 (print)
ISSN 15491676 (online)
URLs:
Notes:
Includes bibliographical references.
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.